
Deere & Company, Corteva, and Gates Industrial are the three Agriculture stocks to watch today, according to MarketBeat’s stock screener tool. Agriculture stocks are shares of publicly traded companies whose main businesses serve the farming and food-production chain — for example, farm equipment manufacturers, seed and agrochemical producers, fertilizer companies, commodity processors, and large agricultural producers or distributors. For investors, these stocks provide exposure to trends in crop prices, weather and yield variability, input costs, global food demand and agricultural policy, which can make their returns more cyclical and commodity-sensitive than many other sectors. These companies had the highest dollar trading volume of any Agriculture stocks within the last several days.
Deere & Company (DE)
Deere & Co. engages in the manufacture and distribution of equipment used in agriculture, construction, forestry, and turf care. It operates through the following segments: Agriculture and Turf, Construction and Forestry, and Financial Services. The Agriculture and Turf segment focuses on the distribution and manufacture of a full line of agriculture and turf equipment and related service parts.
Corteva (CTVA)
Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
Read Our Latest Research Report on CTVA
Gates Industrial (GTES)
Read Our Latest Research Report on GTES
Further Reading
- MarketBeat’s Top Five Stocks to Own in May 2026
- Lilly’s Double-Beat Widens the GLP-1 Gap—And a New Pill Could Make It Permanent
- SanDisk Earnings Crush Estimates With 251% Revenue Surge
- MaxLinear’s Explosive 200% Rally Looks Impressive—But Can It Last?
- 5 Reasons Rambus Stock Price Collapse Is One Hot Entry Point
- Viking Therapeutics Faces Timeline Risk—But Upside Could Be Huge
